Versor Investments LP grew its holdings in shares of Cabot Corporation (NYSE:CBT - Free Report) by 283.9% in the first quarter, according to its most recent filing with the SEC. The firm owned 11,900 shares of the specialty chemicals company's stock after acquiring an additional 8,800 shares during the quarter. Versor Investments LP's holdings in Cabot were worth $989,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. Beverly Hills Private Wealth LLC boosted its position in Cabot by 3.6% during the 1st quarter. Beverly Hills Private Wealth LLC now owns 3,918 shares of the specialty chemicals company's stock worth $326,000 after acquiring an additional 135 shares during the period. Isthmus Partners LLC raised its stake in shares of Cabot by 4.6% in the 1st quarter. Isthmus Partners LLC now owns 4,258 shares of the specialty chemicals company's stock worth $354,000 after buying an additional 186 shares in the last quarter. CWM LLC raised its stake in shares of Cabot by 55.0% in the 1st quarter. CWM LLC now owns 600 shares of the specialty chemicals company's stock worth $50,000 after buying an additional 213 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Cabot by 26.1% in the 1st quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company's stock worth $141,000 after buying an additional 352 shares in the last quarter. Finally, Captrust Financial Advisors raised its stake in shares of Cabot by 4.4% in the 4th quarter. Captrust Financial Advisors now owns 9,489 shares of the specialty chemicals company's stock worth $866,000 after buying an additional 399 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently commented on CBT shares. Wall Street Zen downgraded Cabot from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. UBS Group set a $82.00 price objective on Cabot and gave the stock a "neutral" rating in a research note on Tuesday, August 5th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $92.33.
View Our Latest Report on CBT
Cabot Trading Up 4.9%
Shares of Cabot stock traded up $3.9020 on Friday, reaching $83.0020. 366,335 shares of the company were exchanged, compared to its average volume of 434,107. The stock has a fifty day moving average price of $76.69 and a 200-day moving average price of $78.81. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of 10.85 and a beta of 0.87. The company has a current ratio of 2.13, a quick ratio of 1.41 and a debt-to-equity ratio of 0.66. Cabot Corporation has a fifty-two week low of $70.40 and a fifty-two week high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.80 by $0.10. The company had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot had a return on equity of 25.68% and a net margin of 11.14%. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. On average, analysts expect that Cabot Corporation will post 7.57 EPS for the current year.
Cabot Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Friday, August 29th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.2%. Cabot's dividend payout ratio (DPR) is presently 23.53%.
Insider Activity
In other news, CEO Sean D. Keohane sold 114,436 shares of the business's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares of the company's stock, valued at $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.03% of the stock is owned by company insiders.
About Cabot
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.